Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1641385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Qing Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pulmonary Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Machine Learning, Whole Genome Sequencing, Mycobacterium tuberculosis, Sputum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rifampicin-resistant tuberculosis (RR-TB) remains a major global health challenge, with delayed sputum culture conversion (SCC) predicting poor treatment outcomes. This study integrated whole-genome sequencing (WGS) and machine learning to identify clinical and genomic determinants of SCC failure in 150 RR-TB patients (2019–2023). Phenotypic and genotypic analysis revealed high rates of isoniazid resistance (74.0%) and rpoB mutations (97.3%, predominantly Ser450Leu), with 90% of strains belonging to Lineage 2 (Beijing family). While 64.7% achieved 2-month SCC, 18.0% remained culture-positive at 6 months. Univariate analysis linked 2-month SCC failure to smear positivity, resistance to isoniazid, amikacin, capreomycin, and levofloxacin, and pre-XDR-TB status, though only smear positivity (aOR=2.41, P=0.008) and levofloxacin resistance (aOR=2.83, P=0.003) persisted as independent predictors in multivariable analysis. A Random Forest model achieved robust prediction of SCC failure (AUC: 0.86 ± 0.06 at 2 months; 0.76 ± 0.10 at 6 months), identifying levofloxacin resistance (feature importance: 6.37), embB _p.Met306Ile (5.94), and smear positivity (5.12) as top 2-month predictors, while katG _p.Ser315Thr (4.85) and gyrA _p.Asp94Gly (3.43) dominated 6-month predictions. These findings underscore smear positivity, levofloxacin resistance, and specific resistance mutations as critical drivers of SCC failure, guiding targeted RR-TB treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pulmonary Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Jiaxing Key Laboratory of Clinical Laboratory Diagnostics and Translational Research, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
- Cosmos Wisdom Mass Spectrometry Center of Zhejiang University Medical School, Hangzhou, Zhejiang, China.
- Fountain Valley School, Colorado Springs, CO, United States.
- Institute of Tuberculosis Prevention and Control, Ningbo Municipal Center for Disease Control and Prevention, Ningbo, Zhejiang, China.
Zitieren
APA
Fang, Q., Li, X., Lu, Y., Gao, J., Wu, Y., Chen, Y., & Che, Y. (2025). Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1641385
Vancouver
Fang Q, Li X, Lu Y, Gao J, Wu Y, Chen Y, et al. Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1641385
BibTeX
@article{Fang2025,
author = {Fang, Qing and Li, Xiangchen and Lu, Yewei and Gao, Junshun and Wu, Yvette and Chen, Yi and Che, Yang},
title = {Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1641385}
}
EUVIMED